Rchr
J-GLOBAL ID:200901079500214051   Update date: Apr. 13, 2021

iwanaga masako

iwanaga masako
Research field  (2): Hygiene and public health (non-laboratory) ,  Hematology and oncology
Research keywords  (4): HTLV-1 ,  血液疾患の疫学研究 ,  Hematology ,  Epidemiology
Research theme for competitive and other funds  (23):
  • 2018 - 2021 「HTLV-1総合対策」推進におけるキャリア対策の基盤整備と適正な研究開発の推進に資する包括的評価と提言のための研究
  • 2018 - 2021 HTLV-1キャリアに対するmiRNAを用いたATL発症スクリーニング検査の確立
  • 2017 - 2020 HTLV-1の疫学研究及び総合対策に資する研究
  • 2017 - 2020 ATL/HTLV-1キャリア診療中核施設群の構築によるATLコホート研究
  • 2016 - 2020 ATL発症危険因子の解明:HTLV-1感染者長期追跡コホート研究
Show all
Papers (97):
  • Marina Penova, Shuji Kawaguchi, Jun-ichirou Yasunaga, Takahisa Kawaguchi, Tomoo Sato, Meiko Takahashi, Masakazu Shimizu, Mineki Saito, Kunihiro Tsukasaki, Masanori Nakagawa, et al. Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population. Proceedings of the National Academy of Sciences. 2021. 118. 11. e2004199118-e2004199118
  • Kazumi Nakano, Yohei Chihara, Seiichiro Kobayashi, Masako Iwanaga, Atae Utsunomiya, Toshiki Watanabe, Kaoru Uchimaru. Overexpression of aberrant Wnt5a and its effect on acquisition of malignant phenotypes in adult T-cell leukemia/lymphoma (ATL) cells. Scientific Reports. 2021. 11. 1
  • Shingo Nakahata, Chilmi Syahrul, Ayako Nakatake, Kuniyo Sakamoto, Maki Yoshihama, Ichiro Nishikata, Yoshinori Ukai, Tadashi Matsuura, Takuro Kameda, Kotaro Shide, et al. Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma. Haematologica. 2021. 532-542
  • Imaizumi Y, Iwanaga M, Nosaka K, Ishitsuka K, Ishizawa K, Ito S, Amano M, Ishida T, Uike N, Utsunomiya A, et al. Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study. Cancer Science. 2020
  • Masako Iwanaga. HTLV-1 infection route: Horizontal transmission. Perinatal Medicine (Tokyo). 2020. 50. 10. 1683-1687
more...
MISC (75):
Books (5):
  • 特集:成人T細胞白血病リンパ腫(ATL)研究と診療の進歩 1. HTLV-1感染症の疫学とコホート研究.
    血液内科 2017
  • Adult T-cell Leukemia/Lymphoma
    Springer Japan 2017 ISBN:9784431565215
  • Epidemiology An Introduction
    2013 ISBN:9784884123727
  • Late hematological effects in the atomic bomb survivors. pp 67-72 in Shibata S, Yamashita S, Tomonaga M. (Eds.) Radiation Risk Perspectives. International Congress Series 1299
    Elsevier, Tokyo 2007
  • Chapter 12. Incidence and clinical significance of PNH clone in myelodysplastic syndromes. Paroxysmal Nocturnal Hemoglobinuria and Related Disorders. Molecular Aspects of Pathogenesis.
    2003
Lectures and oral presentations  (6):
  • Comparison of cytogenetic aberration between MDS in A-bomb survivors and therapy-related MDS.
    (2020)
  • Long-term risk of ATL and HAM/TSP in HTLV-1 carriers: an update from JSPFAD
    (JSHAD International Symposium: HTLV-1 infection: Peru, Australia, Japan 2019)
  • Epidemiological aspects of HTLV-1 infection and ATLL in Japan
    (The 19th International conference on Human Retrovirology 2019)
  • Cancer Incidence in Possible Radiation Contaminated Areas, Bayan-Ulgii and Dornod
    (The 10th IPPNW North Asia Regional Conference/3rd North & South Asian IPPNW Meeting, 2018)
  • JSPFADデータベースの現状報告
    (第5回日本HTLV-1学会学術集会 (学士会館) 2018)
more...
Education (3):
  • - 2003 BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH
  • - 1998 Nagasaki University
  • - 1993 Nagasaki University School of Medical Sciences
Professional career (3):
  • MD (Nagasaki University)
  • PhD (Nagasaki University)
  • MPH (Boston University School of Public Health)
Work history (13):
  • 2021/04 - 現在 日本赤十字社長崎原爆病院 医療技術部
  • 2019/10 - 2021/03 Nagasaki Univ. Grad School Biomed Science/Nagasaki Univ. School of Medicine Dep. Clinical Epidemiology
  • 2014/11 - 2019/09 長崎大学医歯薬学総合研究科フロンティア生命科学分野 教授
  • 2013/09 - 2014/11 東京慈恵会医科大学 総合健診予防医学センター講師
  • 2011/11 - 2013/08 帝京大学大学院・公衆衛生学研究科・講師
Show all
Committee career (1):
  • 2020/10 - 2021/03 日本全国がん登録協議会 外部監査委員
Awards (2):
  • 2005/09 - 第67回日本血液学会第47回日本臨床血液学会 優秀ポスター賞 MGUSの疫学:長崎被爆者集団のM蛋白血症スクリーニングに基づく解析
  • 1993/11 - 国際ソロプチミスト日本 南リジョン賞 骨髄異形成症候群の前白血病態及び白血病化の秩序の解明
Association Membership(s) (8):
The Japanese Society of Internal Medicine ,  The Japanese Society of Clinical Hematology ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  日本臨床疫学会 ,  THE JAPANESE CANCER ASSOCIATION ,  International Retrovirology Association (IRVA) ,  Japanese Society of HTLV-1 and Associated Disease ,  American Society of Hematology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page